← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 28, 2007Last known activity
Jul 28, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03208270CollaboratorPhase 3Jul 28, 2017
- NCT01441934Reponsible party - principal investigatorPhase 3Oct 1, 2010
- NCT01013194Lead sponsorPhase 1/Phase 2Feb 28, 2007
Details
- Last known activity
- Jul 28, 2017